TY  - JOUR
T1  - REsearchers still seek clinical benefit in raising levels of good cholesterol
AU  - Mitka M
Y1  - 2012/01/04
N1  - 10.1001/jama.2011.1871
JO  - JAMA
SP  - 21
EP  - 22
VL  - 307
IS  - 1
N2  - 
A hypothesis that is embraced by many in the medical community involves high-density lipoprotein cholesterol (HDL-C), the “good cholesterol.” Epidemiologic studies have found an inverse association between HDL-C levels and the rates of coronary heart disease events, so researchers theorize that raising HDL-C levels might reduce adverse coronary outcomes. However, proof of the theory remains outside researchers' grasp, as shown in studies presented at the American Heart Association's Scientific Sessions, held here in November.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2011.1871
UR  - http://dx.doi.org/10.1001/jama.2011.1871
ER  -